Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Legal-Education Plus Trauma-informed Therapy to Improve Community Acceptance and Reintegration of Repentant Terrorists in Nigeria (LETiT)

25 de mayo de 2022 actualizado por: Dr Dung Jidong, PhD, Nottingham Trent University

Legal-Education Plus Trauma-informed Therapy to Improve Community Acceptance and Reintegration of Repentant Terrorists in Nigeria: A Pilot Randomised Controlled Trial

Terrorism is an issue of global concern, and reintegrating repentant terrorists, including their families, has often proved challenging considering the damages done by the terrorist group. Despite Boko Haram atrocities in Nigeria, the focus seems directed toward the repentant terrorists with limited attention to the communities, the trauma they suffered, and their involvement in the design of reintegration programmes. There is also limited community awareness of legal support channels to foster positive reintegration (Ike et al., 2021). The implication is that it risks undermining the social context that informs successful reintegration, improves acceptance, and reduces reoffending. However, there appears to be limited research on this important policy problem in Nigeria. Our study proposes to fill this gap by contributing to the research initiative through a novel cross-disciplinary intervention drawing on law and psychology entitled Legal Education plus Trauma-informed Therapy (LETiT) to improve community acceptance and reintegration of repentant terrorists in Nigeria.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

150

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Dung Jidong, PhD
  • Número de teléfono: +44 115 84 86478
  • Correo electrónico: dung.jidong@ntu.ac.uk

Copia de seguridad de contactos de estudio

  • Nombre: Tarela Ike, PhD
  • Número de teléfono: +44 1642 34 2316
  • Correo electrónico: t.ike@tees.ac.uk

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 85 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • ages 18 - 85 years
  • able to give consent
  • able to understand and speak English
  • score a minimum of 5 on Trauma Screening Questionnaire
  • residents of designated communities of intervention (Adamawa, Maiduguri, and Plateau states)
  • available for the study and follow up at 3- and 6-months post-intervention

Exclusion Criteria:

  • less than 18 or above 85 years
  • unable to give consent
  • clinically diagnosed with severe PTSD/suicidal ideations or undergoing treatment
  • temporary or non-residents who are unlikely to be available for follow up

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: LETiT

The LETiT intervention will cover (a) Legal education with numerous aspects relating to human rights, access to legal support and tackling traumatic experiences.

(b) The Trauma-informed Therapy component will involve addressing trauma, dispelling negative thoughts and building more positive thinking.

It is worth adding that the LETiT intervention has undergone standardisation of procedure by adopting a coherent manual (e.g., the Legal Education plus Trauma-informed Therapy manual) specifically designed for the proposed intervention. For example, the legal education contents are collated from extant laws, including the 1999 Constitution of the Federal Republic of Nigeria.

Group-1: Experimental (n=75 participants) will receive the LETiT which consists of a total of 12-group integrated sessions lasting approximately 60-90 minutes per session every week with 20-25 persons per sub-group.
Comparador activo: Intervention As Usual (IAU)

The Intervention As Usual (IAU) component of the proposed project is designed through a systematic collation of numerous government and non-governmental organisations' support information (e.g., news information and basic re-orientation of community members affected by terrorism). Thus, the IAU group will receive the government intervention involving media messages from the National Orientation Agency devoid of legal education or trauma-informed therapy.

The training materials are organised to address key aspects of care such as (a) acknowledgement of the severity of lived experiences (b) reflection of current help received from the government and humanitarian services (c) essential aspects of self-care and caring for the vulnerable family and community members (d) inspiration for the future etc.

Group-2: Controlled (n=75 participants) will receive the IAU which consists of a total of 12-group integrated sessions lasting approximately 60-90 minutes per session every week with 20-25 persons per sub-group.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Trauma Screening Questionnaire
Periodo de tiempo: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in traumatic experience is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Adaptive Stress Index
Periodo de tiempo: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in stress is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Patient Health Questionnaire
Periodo de tiempo: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in depression is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Generalised Anxiety Disorder Scale
Periodo de tiempo: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in anxiety is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Legal-Education Awareness Scale
Periodo de tiempo: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in awareness of human right is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Attitude Towards Repentant Terrorists and their Reintegration Scale
Periodo de tiempo: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in of attitude towards repentant terrorists is being assessed
Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
brief Verona Service Satisfaction Scale
Periodo de tiempo: Change is being assessed at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention
Change in service satisfaction is being assessed
Change is being assessed at 12 weeks end of intervention, at 3-months, and at 6-months post-intervention

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Dung Jidong, PhD, Nottingham Trent University, UK

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Anticipado)

20 de junio de 2022

Finalización primaria (Anticipado)

19 de junio de 2023

Finalización del estudio (Anticipado)

30 de septiembre de 2023

Fechas de registro del estudio

Enviado por primera vez

25 de mayo de 2022

Primero enviado que cumplió con los criterios de control de calidad

25 de mayo de 2022

Publicado por primera vez (Actual)

31 de mayo de 2022

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

31 de mayo de 2022

Última actualización enviada que cumplió con los criterios de control de calidad

25 de mayo de 2022

Última verificación

1 de mayo de 2022

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 0000-0001-5034-0335d

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir